The team celebrated a major milestone in February with the launch of the upgraded digital experience for Claims Rx, amongst other key publications.
The use of non-FDA-approved medical products and approved products used off-label in the delivery of healthcare is common. While multiple clinical scenarios may necessitate the use of medical products in this fashion, there are associated liability exposures to be aware of to properly mitigate. Both professional and product liability exposures will be examined through closed-claim examples centered on the use of non-FDA-approved medical products. Risk mitigation strategies will be provided based on lessons learned from claims to avoid common pitfalls in a clinical practice and improve patient safety.
Read it here.
We are proud to announce that a digital version of our bimonthly Claims Rx publication is now available! This convenient web-based model provides the same insightful articles as our PDF version, featuring claims-based learning, valuable risk management advice, and applicable and effective risk reduction strategies. This digital option has several upgrades:
The Allegation
The physician negligently introduced morphine and subsequently doubled the prescription one day prior to the patient's death.
Case Background
A 40 YOM with a history of chronic back pain presented to establish care with a family practice physician. The physician and nurse practitioner managed his ongoing chronic low back pain, asthma, type 2 diabetes, lower extremity pain, depression, and anxiety.
Read the full case here.
This course will educate learners about social determinants of health (SDOH) and their impact on patient outcomes. The purpose of this presentation is to help clinicians better support patients who are impacted by certain social barriers so they may receive equal care. The learner will understand how personal bias affects patient care and how to reduce bias during the delivery of care. Patients' previously experienced trauma and the downstream effect of future care rendered will also be discussed. In addition, the learner will understand how negative labels and documentation may affect the care patients receive.
See a preview here.
This episode delves into GLP-1 agonists, a class of medications that have gained popularity for diabetes and weight management. The discussion covers the risks associated with prescribing these medications, including on-label and off-label uses, the role of compounding pharmacies, and the importance of shared decision-making between healthcare providers and patients. Experts highlight the challenges posed by medication shortages and the potential dangers of compounded drugs, emphasizing the need for thorough patient education and careful selection of pharmacies.